Last reviewed · How we verify

NCT06812975

Paceport Swan-Ganz Data Collection Study

Completed Last updated 1 August 2025
What this trial tests

trial testing No intervention in RV Dysfunction in 152 participants. Completed in 8 July 2025.

Timeline
18 September 2021
Primary endpoint
8 July 2025
8 July 2025

Quick facts

Lead sponsorUniversity of Minnesota
StatusCompleted
Study typeOBSERVATIONAL
Enrollment152
Start date18 September 2021
Primary completion8 July 2025
Estimated completion8 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Minnesota

Who can join

18 and older, any sex, with RV Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In association with Edwards LifeSciences, the study will aim to develop an algorithm based on right heart (right atrial, right ventricular and pulmonary artery) waveforms for the early detection of RV dysfunction in cardiothoracic and liver surgery patients at UMMC. This is a prospective, non-interventional, observational study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for RV Dysfunction

Currently open trials in the same condition.

Other University of Minnesota trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06812975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing